期刊文献+

肿瘤的多肽疫苗

Tumor peptide vaccine
下载PDF
导出
摘要 肿瘤疫苗是目前肿瘤生物治疗的有效方法之一,用肿瘤抗原多肽作为肿瘤疫苗具有一定的优越性。多肽疫苗在临床试验中已取得了一定的效果,如和树突状细胞联合应用可以提高其免疫效果,但在临床应用中也应注意避免自身免疫的发生。 Tumor vaccine is one of the effective antitumor bio-therapy methods.Using tumor antigen peptide as tumor vaccine has certain superiority.Several clinical studies related to peptide vaccine have gained some good results.Using peptide pulse dendritic cells as tumor vaccine will enhance its effects,but autoimmune diseases should be avoided in clinical activities.
出处 《齐鲁药事》 2005年第4期228-230,共3页 qilu pharmaceutical affairs
关键词 肿瘤 多肤疫苗 tumor peptide vaccine
  • 相关文献

参考文献15

  • 1Rosenberg SA.Progress in human tumour immunology and immunotherapy.Nature,2001,411:380~384.
  • 2Chang CC,Campoli M,Ferrone S.HLA class I antigen expression in malignant cells:why does it not always correlate with CTL-mediated lysis? Curr Opin Immunol,2004,16:644~650.
  • 3Rammensee H,Bachmann J,Emmerich NP,et al.SYFPEITHI:database for MHC ligands and peptide motifs.Immunogenetics,1999,50∶213~219.
  • 4Sarobe P,Huarte E,Lasarte JJ,et al.Carcinoembryonic antigen as a target to induce anti-tumor immune responses.Curr Cancer Drug Targets,2004,4:443~454.
  • 5Zeng G,Li Y,El Gamil M,et al.Generation of NY-ESO-1-specific CD4+ and CD8+ T cells by a single peptide with dual MHC class Ⅰ and class Ⅱ specificities:a new strategy for vaccine design.Cancer Res,2002,62:3630~3635.
  • 6Bellone M,Cantarella D,Castiglioni P,et al.Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma.J Immunol,2000,165:2651~2656.
  • 7Labeur MS,Roters B,Pers B,et al.Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage.J Immunol,1999,162:168~175.
  • 8Eggert AA,Schreurs MW,Boerman OC,et al.Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration.Cancer Res,1999,59:3340~3345.
  • 9Parmiani G,Castelli C,Dalerba P,et al.Cancer immunotherapy with peptide-based vaccines:what have we achieved? Where are we going? J Natl Cancer Inst,2002,94:805~818.
  • 10Talebi T,Weber JS.Peptide vaccine trials for melanoma:preclinical background and clinical results.Semin Cancer Biol,2003,13:431~438.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部